Oruka Therapeutics (ORKA) Assets (2010 - 2026)

Oruka Therapeutics' Assets history runs 17 years deep, the most recent figure standing at $504.5 million for Q1 2026.

• In Q1 2026, Assets rose 33.77% year-over-year to $504.5 million; the TTM figure through Mar 2026 stood at $504.5 million (up 33.77% YoY), while the FY2025 annual figure was $488.6 million, up 23.38% from the prior year.
• Assets was $504.5 million for Q1 2026 at Oruka Therapeutics, up from $488.6 million in the prior quarter.
• In the past five years, Assets ranged from a high of $509.3 million in Q3 2025 to a low of $33.8 million in Q2 2024.
• Historically, Assets has averaged $203.8 million across 5 years, with a median of $48.1 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Assets decreased 26.38% in 2022, then jumped 956.78% in 2024.
• A 5-year view of Assets shows it stood at $43.1 million in 2022, then retreated by 12.12% to $37.9 million in 2023, then jumped by 945.98% to $396.0 million in 2024, then climbed by 23.38% to $488.6 million in 2025, then advanced by 3.25% to $504.5 million in 2026.
• The last three Assets figures came in at $504.5 million (Q1 2026), $488.6 million (Q4 2025), and $509.3 million (Q3 2025), per Business Quant data.